Your browser doesn't support javascript.
loading
Isoniazid-associated pellagra during mass scale-up of tuberculosis preventive therapy: a case-control study.
Nabity, Scott A; Mponda, Kelvin; Gutreuter, Steve; Surie, Diya; Zimba, Suzgo B; Chisuwo, Laphiod; Moffitt, Allison; Williams, Anne M; Sharma, Andrea J; Marshall, Rebekah E; Chiwaula, Mabvuto J; da Silva, Robin; Kumwenda, Tapiwa; Chilikutali, Lloyd; Mwamale, Shallom; Nagoli, Esther; Mwenyeheri, Gerald; Ngongonda, Dingase; Kaunda, Esther; Mtoto, Fredrick; Mhango, Vorster; Mbewe, Khumbo; Melgar, Michael; Odo, Michael; Jahn, Andreas; Buono, Nicole; Maida, Alice; Girma, Belaineh; Kalua, Thokozani; Nyirenda, Rose; Sunguti, Joram; Woelk, Godfrey; Gunde, Laurence J; Mekonnen, Tigest F; Maphosa, Thulani; Kim, Evelyn J; Auld, Andrew F; Muula, Adamson S; Oeltmann, John E.
Affiliation
  • Nabity SA; Division of Global HIV and Tuberculosis, US Centers for Disease Control and Prevention, Atlanta, GA, USA. Electronic address: hjq5@cdc.gov.
  • Mponda K; Department of Medicine, Kamuzu University of Health Sciences, Blantyre, Malawi.
  • Gutreuter S; Division of Global HIV and Tuberculosis, US Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Surie D; Division of Global HIV and Tuberculosis, US Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Zimba SB; Elizabeth Glaser Pediatric AIDS Foundation, Lilongwe, Malawi.
  • Chisuwo L; National Public Health Reference Laboratory, Public Health Institute of Malawi, Lilongwe, Malawi.
  • Moffitt A; Division of Global HIV and Tuberculosis, US Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Williams AM; National Center for Chronic Disease Prevention and Health Promotion, US Centers for Disease Control and Prevention, Atlanta, GA, USA; McKing Consulting Corporation, Atlanta, GA, USA.
  • Sharma AJ; National Center for Chronic Disease Prevention and Health Promotion, US Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Marshall RE; Division of Global HIV and Tuberculosis, US Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Chiwaula MJ; National Public Health Reference Laboratory, Public Health Institute of Malawi, Lilongwe, Malawi.
  • da Silva R; Department of Food Science and Human Nutrition, University of Florida, Gainesville, FL, USA.
  • Kumwenda T; Lighthouse Trust, Lilongwe, Malawi.
  • Chilikutali L; Elizabeth Glaser Pediatric AIDS Foundation, Lilongwe, Malawi.
  • Mwamale S; Elizabeth Glaser Pediatric AIDS Foundation, Lilongwe, Malawi.
  • Nagoli E; Department of Clinical Services, Malawi Ministry of Health, Lilongwe, Malawi.
  • Mwenyeheri G; Elizabeth Glaser Pediatric AIDS Foundation, Lilongwe, Malawi.
  • Ngongonda D; Department of Clinical Services, Malawi Ministry of Health, Lilongwe, Malawi.
  • Kaunda E; Department of Clinical Services, Malawi Ministry of Health, Lilongwe, Malawi.
  • Mtoto F; Department of Clinical Services, Malawi Ministry of Health, Lilongwe, Malawi.
  • Mhango V; Department of Clinical Services, Malawi Ministry of Health, Lilongwe, Malawi.
  • Mbewe K; Department of Clinical Services, Malawi Ministry of Health, Lilongwe, Malawi.
  • Melgar M; Division of Global HIV and Tuberculosis, US Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Odo M; Department of HIV and AIDS, Malawi Ministry of Health, Lilongwe, Malawi.
  • Jahn A; Department of HIV and AIDS, Malawi Ministry of Health, Lilongwe, Malawi.
  • Buono N; Division of Global HIV and Tuberculosis, US Centers for Disease Control and Prevention, Lilongwe, Malawi.
  • Maida A; Division of Global HIV and Tuberculosis, US Centers for Disease Control and Prevention, Lilongwe, Malawi.
  • Girma B; National Tuberculosis Control Program, Malawi Ministry of Health, Lilongwe, Malawi.
  • Kalua T; Department of HIV and AIDS, Malawi Ministry of Health, Lilongwe, Malawi.
  • Nyirenda R; Department of HIV and AIDS, Malawi Ministry of Health, Lilongwe, Malawi.
  • Sunguti J; Elizabeth Glaser Pediatric AIDS Foundation, Lilongwe, Malawi.
  • Woelk G; Elizabeth Glaser Pediatric AIDS Foundation, Lilongwe, Malawi.
  • Gunde LJ; Division of Global HIV and Tuberculosis, US Centers for Disease Control and Prevention, Lilongwe, Malawi.
  • Mekonnen TF; Division of Global HIV and Tuberculosis, US Centers for Disease Control and Prevention, Lilongwe, Malawi.
  • Maphosa T; Elizabeth Glaser Pediatric AIDS Foundation, Lilongwe, Malawi.
  • Kim EJ; Division of Global HIV and Tuberculosis, US Centers for Disease Control and Prevention, Lilongwe, Malawi.
  • Auld AF; Division of Global HIV and Tuberculosis, US Centers for Disease Control and Prevention, Lilongwe, Malawi.
  • Muula AS; School of Public Health and Family Medicine, Kamuzu University of Health Sciences, Blantyre, Malawi.
  • Oeltmann JE; Division of Global HIV and Tuberculosis, US Centers for Disease Control and Prevention, Atlanta, GA, USA.
Lancet Glob Health ; 10(5): e705-e714, 2022 05.
Article in En | MEDLINE | ID: mdl-35427527
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Pellagra / Tuberculosis / HIV Infections / Isoniazid / Antitubercular Agents Type of study: Observational_studies / Risk_factors_studies Limits: Female / Humans / Male Language: En Journal: Lancet Glob Health Year: 2022 Type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Pellagra / Tuberculosis / HIV Infections / Isoniazid / Antitubercular Agents Type of study: Observational_studies / Risk_factors_studies Limits: Female / Humans / Male Language: En Journal: Lancet Glob Health Year: 2022 Type: Article